PC Pharma Limited - Colombo Stock Exchange

More documents

Recommendations

Info

10. Corporate Governance Practices The Board of Directors of PC Pharma Limited has given the due emphasis to the importance of highest standard corporate governance practices in promoting business integrity, accountability and transparency. The following framework forms the of Corporate Governance code of the Company. Constitution of the Board The Company has two Executive Directors, two Non-Executive Directors and two Non- Executive Independent Directors on the Board with the expertise mainly in the areas of financial management, general management and operations of Pharmaceutical companies. Non-Executive Directors The Board of PC Pharma Limited consists of the following Non-Executive Directors. � Mrs. Sithy Sharmila Rishan � Mr. Prasanna Lakshantha Wijesekara � Mr. Ramasamy Selvaraj � Mrs. Shanthi Sri Nanda Goonaratne Non-Executive Independent Directors The following directors of PC Pharma Limited have fulfilled the requirements to be Non- Executive Independent Directors of the Company. � Mr. Ramasamy Selvaraj � Mrs. Shanthi Sri Nanda Goonaratne Remuneration Committee The Remuneration Committee consists of two Independent Non-Executive Directors and one Non-Executive Director. Mr. Ramasamy Selvaraj functions as the Chairman of the Remuneration Committee. � Mr. Ramasamy Selvaraj – Non Executive Independent Director � Mrs. Shanthi Sri Nanda Goonaratne – Non Executive Independent Director � Mr. Prasanna Lakshantha Wijesekara – Non Excutive Director The Remuneration Committee is responsible for making recommendations to the Board on the remuneration of Executive Directors and Non-Executive Directors. The committee is also responsible for setting up the remuneration policy, which provides guidelines to the Board on the overall remuneration framework to ensure that remuneration levels are at a satisfactory level to attract and retain the requisite professionals to support the success of the Company. 44 Introductory Document – PC Pharma Limited
Audit Committee The Audit Committee comprises of the following one Non-Executive Director and two Independent Non-Executive Directors. � Mr. Prasanna Lakshantha Wijesekara – Non-Executive Director � Mr. Ramasamy Selvaraj – Non Executive Independent Director � Mr. Shanthi Sri Nanda Goonaratne – Non-Executive Independent Director Mr. Prasanna Lakshantha Wijesekara functions as the Chairman of the Audit Committee. The Chief Executive Officer and the Finance Manager attends meetings of the Audit Committee by invitation. The Audit Committee is responsible for reviewing the functions and processes of internal controls in the Company and ensuring the effectiveness of such controls. The Committee monitors all audit activities and operations and ensures their compliance with overall policies and procedures as well as adherence to statutory and regulatory requirements and industry best practices. Introductory Document – PC Pharma Limited 45
Page 3: PC Pharma Limited Introductory Docu
Page 7: Abbreviations CBSL Central Bank of
Page 10 and 11: 5. 5.1 5.2 5.3 5.4 6. 6.1 6.2 7. 7.
Page 12 and 13: Board of Directors Mr. Saheedul Hij
Page 14 and 15: CT Smith Stockbrokers (Pvt) Limited
Page 16 and 17: 3. 3.1 3.2 Overview of the Healthca
Page 18 and 19: Table 3.1: Health Sector Infrastruc
Page 20 and 21: Guidelines are in place making it m
Page 22 and 23: 3.5 pharmaceuticals covering a wide
Page 24 and 25: 4. 4.1 Company Profile Group Overvi
Page 26 and 27: 4.3 Pharmaceutical items of superio
Page 28 and 29: 4.5 The company is also involved in
Page 30 and 31: 4.6 Distribution PC Pharma Limited
Page 32 and 33: 4.7 Financial Highlights Salient ex
Page 34 and 35: 4.8 Key Financial Ratios The key fi
Page 36 and 37: 4.11 4.12 IT Infrastructure The per
Page 38 and 39: 5.2 5.3 Underlying Assumptions on W
Page 40 and 41: Risk associated with the Manufactur
Page 42 and 43: Introductory Document - PC Pharma L
Page 44 and 45: Natasha Antoinette Abeyagoonasekera
Page 46 and 47: 7.2 Share Capital Share Allotments
Page 48 and 49: Distribution of Shareholding Distri
Page 50 and 51: 8.1 Mrs. Shanthi Sri Nanda Goonarat
Page 52 and 53: 8.5 8.6 Director’s Emoluments Emo
Page 56 and 57: 11. Statutory Declaration Declarati
Page 58 and 59: Audited Financial Statements 48 Int
Page 60 and 61: 50 Introductory Document - PC Pharm
Page 74 and 75: Annexure II - Auditors Report and F
Page 104 and 105:
94 Introductory Document - PC Pharm
Page 106 and 107:
Interim Financial Statements 96 Int
Page 108 and 109:
98 Introductory Document - PC Pharm
show all

PC Pharma Limited - Colombo Stock Exchange

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?